Butanoyl PAF, a compound closely related to Azelaoyl PC ( HY-134154 ), maintains over 10% of the agonist potency of platelet-activating factor ( PAF ). Butanoyl PAF's concentration in oxidized low-density lipoprotein surpasses that of enzymatically generated PAF by more than 100-fold.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Platelet-activating Factor Receptor (PAFR)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.